all report title image

Point of Care Diagnostics Market, By Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drugs of Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, Others), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI1515
  • Pages :148
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic
Ingographics Image

Point of care (POC) diagnostics refers to medical diagnostic testing performed outside a laboratory, near or at the site of patient care. Traditionally, most diagnostic tests were conducted in centralized laboratories. However, POC diagnostics helps deliver faster results, enable quick clinical decisions, and provide treatment immediately without transferring samples to distant labs. Technological advancements have enabled the development of portable and easy-to-use devices suitable for near-patient settings like doctor's offices, emergency rooms, pharmacies, and homes. Rising demand for rapid testing and decentralized healthcare, increasing incidence of infectious diseases and growing elderly population susceptible to chronic conditions can drive the global point of care diagnostics market growth.

Market Dynamics:

Global point of care diagnostics market growth is driven by factors like growing demand for rapid, convenient and real-time test results, increasing prevalence of chronic and infectious diseases, rising geriatric population worldwide, technological advancements leading to development of user-friendly and portable POC devices. However, lack of infrastructure and skilled professionals in developing nations, high cost of advanced POC devices, and unreliable test results associated with some devices can hamper the market growth. Moreover, untapped opportunities in emerging markets, integration of advanced technologies like AI and IoT with POC devices, and growing applications of POC testing in home healthcare can offer significant opportunities for the market players.

Key features of the study:

- This report provides in-depth analysis of the global point of care diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global point of care diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global point of care diagnostics market

 Detailed Segmentation-

  • By Technology Insights (Revenue, USD Bn, 2019 - 2031)
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
    • Biosensors
  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Cardio Metabolic Testing
    • Infectious Disease Testing
    • Nephrology Testing
    • Drugs of Abuse (DoA) Testing
    • Blood Glucose Testing
    • Pregnancy Testing
    • Cancer Biomarker Testing
    • Others
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Becton, Dickinson and Company
    • Qiagen Inc.
    • Johnson & Johnson Services, Inc.
    • Danaher Corporation (Beckman Coulter Inc.)
    • Instrumentation Laboratory
    • Nova Biomedical Corporation
    • Biomeriux SA
    • GE Healthcare
    • Philips Healthcare
    • Quest Diagnostics
    • Fujifilm Medical
    • Thermo Fisher Scientific
    • Hologic
    • Canon
    • IDEXX Laboratories
    • Sysmex
    • QuidelOrtho

 Detailed Segmentation-

  • By Technology Insights (Revenue, USD Bn, 2019 - 2031)
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
    • Biosensors
  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Cardio Metabolic Testing
    • Infectious Disease Testing
    • Nephrology Testing
    • Drugs of Abuse (DoA) Testing
    • Blood Glucose Testing
    • Pregnancy Testing
    • Cancer Biomarker Testing
    • Others
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.